drugset / Trial / NCT01511731
Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study was to compare the single-dose relative bioavailability of Reddy Cheminor and Merck \&Co, pepcid 40 mg famotidine tablets under fasting conditions.
Timeline
- Start
- 1998-10
- Primary completion
- 1998-10
- Completion
- 1998-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Famotidine | Other / unclassified | 40 mg | Oral |
Indications
No indication recorded.